BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23600288)

  • 1. [Quality of life of patients with locally advanced operated gastric cancer during the period of chemotherapy].
    Manikhas GM; Zhukova NV
    Vopr Onkol; 2012; 58(5):679-83. PubMed ID: 23600288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy for locally advanced gastric cancer].
    Kalmár K; Cseke L; Káposztás Z; Horváth G; Varga E
    Magy Seb; 2003 Oct; 56(5):177-84. PubMed ID: 15022621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
    Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy.
    Jeung HC; Rha SY; Jang WI; Noh SH; Chung HC
    Br J Surg; 2002 Apr; 89(4):460-6. PubMed ID: 11952588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
    Kim JS; Kim MA; Oh DY; Lee SH; Kim DW; Im SA; Kim WH; Yang HK; Heo DS; Bang YJ; Lee KU; Kim TY; Kim TM; Kim NK; Choe KJ
    Jpn J Clin Oncol; 2011 Feb; 41(2):245-52. PubMed ID: 21106599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Anticancer Res; 2007; 27(5B):3535-9. PubMed ID: 17972514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
    Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
    Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].
    Lu M; Shen L; Li J; Li Y; Zhang XD
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):392-5. PubMed ID: 19799092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intermittent 5-fluorouracil and low-dose cisplatin therapy on advanced and recurrent gastric cancer.
    Kanetaka K; Enjoji A; Furui J; Nagata Y; Fujioka H; Shiogama T; Miyata A; Kishikawa H; Matsuo S; Iwata T; Kanematsu T; Eguchi S;
    Anticancer Res; 2012 Aug; 32(8):3495-9. PubMed ID: 22843936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
    Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
    Amini A; Sanati H
    Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.
    Park SH; Lee WK; Chung M; Bang SM; Cho EK; Lee JH; Shin DB
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):289-94. PubMed ID: 16010588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].
    Káposztás Z; Cseke L; Kalmár K; Horváth OP
    Magy Seb; 2002 Oct; 55(5):321-4. PubMed ID: 12474518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.